Questionable antipsychotic prescribing remains common, despite serious risks
JAMA
.
2010 Apr 28;303(16):1582-4.
doi: 10.1001/jama.2010.453.
Author
Bridget M Kuehn
PMID:
20424239
DOI:
10.1001/jama.2010.453
No abstract available
Publication types
News
MeSH terms
Antipsychotic Agents / adverse effects*
Antipsychotic Agents / therapeutic use
Humans
Off-Label Use
Practice Patterns, Physicians'*
Psychiatry
United States
United States Food and Drug Administration
Substances
Antipsychotic Agents